{"transactions":[{"id":1624647,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2024-02-23T01:06:17.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":19294,"price":8.92,"value":172102.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":314915,"source":{"system":"sec-edgar","filing":"0001415889-24-004960","document":"form4-02232024_010210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924004960/form4-02232024_010210.xml","form_type":"4"}},{"id":1730781,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-11-22T23:10:03.000Z","date":"2023-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12630,"price":10.37,"value":130973.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":334209,"source":{"system":"sec-edgar","filing":"0001415889-23-015448","document":"form4-11222023_111154.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923015448/form4-11222023_111154.xml","form_type":"4"}},{"id":1738652,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-11-16T23:16:33.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":2482,"price":10.22,"value":25366.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":346839,"source":{"system":"sec-edgar","filing":"0001415889-23-015228","document":"form4-11162023_111124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923015228/form4-11162023_111124.xml","form_type":"4"}},{"id":1752358,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-11-01T22:35:45.000Z","date":"2023-10-30","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2023 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of a performance condition by December 31, 2023 and continued employment. On October 30, 2023 the performance conditions were achieved. As a result 50% of the restricted stock units will vest on November 20, 2023 and the remaining 50% of the restricted stock units will vest on November 20, 2024, subject to the reporting person's continued service."}],"balance_after":349321,"source":{"system":"sec-edgar","filing":"0001415889-23-014680","document":"form4-11012023_101136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923014680/form4-11012023_101136.xml","form_type":"4"}},{"id":1757931,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-10-18T22:54:17.000Z","date":"2023-10-16","kind":"sale","planned":true,"acquired":false,"shares":2482,"price":9.03,"value":22412.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":334321,"source":{"system":"sec-edgar","filing":"0001415889-23-014412","document":"form4-10182023_101010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923014412/form4-10182023_101010.xml","form_type":"4"}},{"id":1778654,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-09-18T22:08:53.000Z","date":"2023-09-14","kind":"sale","planned":true,"acquired":false,"shares":2482,"price":9.89,"value":24546.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":336803,"source":{"system":"sec-edgar","filing":"0001415889-23-013342","document":"form4-09182023_100948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923013342/form4-09182023_100948.xml","form_type":"4"}},{"id":1799425,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-08-22T22:13:01.000Z","date":"2023-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":10461,"price":9.7,"value":101471.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":339285,"source":{"system":"sec-edgar","filing":"0001415889-23-012514","document":"form4-08222023_100854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923012514/form4-08222023_100854.xml","form_type":"4"}},{"id":1807010,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:09:43.000Z","date":"2023-08-11","kind":"sale","planned":true,"acquired":false,"shares":2322,"price":9.99,"value":23196.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":349746,"source":{"system":"sec-edgar","filing":"0001415889-23-012271","document":"form4-08152023_100836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923012271/form4-08152023_100836.xml","form_type":"4"}},{"id":1827625,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-07-18T22:14:58.000Z","date":"2023-07-14","kind":"sale","planned":false,"acquired":false,"shares":2322,"price":9.84,"value":22848.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":352068,"source":{"system":"sec-edgar","filing":"0001415889-23-011244","document":"form4-07182023_100756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923011244/form4-07182023_100756.xml","form_type":"4"}},{"id":1851405,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-06-16T22:14:04.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":2322,"price":10.69,"value":24822.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":354390,"source":{"system":"sec-edgar","filing":"0001415889-23-009963","document":"form4-06162023_100650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923009963/form4-06162023_100650.xml","form_type":"4"}},{"id":1880760,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-05-23T23:41:49.000Z","date":"2023-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":10460,"price":11.21,"value":117256.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":356712,"source":{"system":"sec-edgar","filing":"0001415889-23-008670","document":"form4-05232023_110546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923008670/form4-05232023_110546.xml","form_type":"4"}},{"id":1888400,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-05-17T22:17:38.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":2322,"price":11.26,"value":26145.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":367172,"source":{"system":"sec-edgar","filing":"0001415889-23-008228","document":"form4-05172023_100533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923008228/form4-05172023_100533.xml","form_type":"4"}},{"id":1917877,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-04-18T21:49:36.000Z","date":"2023-04-14","kind":"sale","planned":false,"acquired":false,"shares":2323,"price":11.88,"value":27597.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":369494,"source":{"system":"sec-edgar","filing":"0001415889-23-006620","document":"form4-04182023_090429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923006620/form4-04182023_090429.xml","form_type":"4"}},{"id":1949639,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-03-16T23:04:18.000Z","date":"2023-03-14","kind":"sale","acquired":false,"shares":2323,"price":10.32,"value":23973.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":371817,"source":{"system":"sec-edgar","filing":"0001415889-23-005044","document":"form4-03162023_110312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923005044/form4-03162023_110312.xml","form_type":"4"}},{"id":1962588,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-03-09T00:34:51.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":2323,"price":10.05,"value":23346.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22."}],"balance_after":374140,"source":{"system":"sec-edgar","filing":"0001415889-23-004552","document":"form4-03092023_120346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923004552/form4-03092023_120346.xml","form_type":"4"}},{"id":1971667,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-03-04T01:32:40.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":376463,"source":{"system":"sec-edgar","filing":"0001415889-23-004271","document":"form4-03042023_010324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923004271/form4-03042023_010324.xml","form_type":"4"}},{"id":1998651,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2023-02-23T00:21:03.000Z","date":"2023-02-20","kind":"tax_withholding","acquired":false,"shares":12057,"price":10.44,"value":125875.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":301463,"source":{"system":"sec-edgar","filing":"0001415889-23-003065","document":"form4-02232023_120239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923003065/form4-02232023_120239.xml","form_type":"4"}},{"id":2095552,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-12-05T22:59:30.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":2084,"price":10.73,"value":22361.32,"ownership":{"direct":true},"balance_after":313520,"source":{"system":"sec-edgar","filing":"0001415889-22-012077","document":"form4-12052022_101216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922012077/form4-12052022_101216.xml","form_type":"4"}},{"id":2106370,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-11-22T21:04:46.000Z","date":"2022-11-20","kind":"tax_withholding","acquired":false,"shares":27350,"price":10.85,"value":296747.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":315604,"source":{"system":"sec-edgar","filing":"0001415889-22-011669","document":"form4-11222022_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922011669/form4-11222022_091137.xml","form_type":"4"}},{"id":2111558,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, RESEARCH & DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-11-18T00:53:38.000Z","date":"2022-11-16","kind":"tax_withholding","acquired":false,"shares":2800,"price":11.2,"value":31360.0,"ownership":{"direct":true},"balance_after":342954,"source":{"system":"sec-edgar","filing":"0001415889-22-011523","document":"form4-11182022_121128.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922011523/form4-11182022_121128.xml","form_type":"4"}},{"id":2175795,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-08-23T22:57:57.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":18991,"price":9.34,"value":177375.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":345754,"source":{"system":"sec-edgar","filing":"0001415889-22-008981","document":"form4-08232022_030844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922008981/form4-08232022_030844.xml","form_type":"4"}},{"id":2179119,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-08-18T22:05:26.000Z","date":"2022-08-16","kind":"sale","acquired":false,"shares":4906,"price":9.7105,"value":47639.713,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $9.71 to $9.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":364745,"source":{"system":"sec-edgar","filing":"0001415889-22-008835","document":"form4-08182022_030816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922008835/form4-08182022_030816.xml","form_type":"4"}},{"id":2187797,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-08-11T22:55:30.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":15086,"price":8.79,"value":132605.94,"ownership":{"direct":true},"balance_after":369651,"source":{"system":"sec-edgar","filing":"0001415889-22-008512","document":"form4-08112022_030815.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922008512/form4-08112022_030815.xml","form_type":"4"}},{"id":2257768,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-05-24T23:14:36.000Z","date":"2022-05-20","kind":"tax_withholding","acquired":false,"shares":3947,"price":8.74,"value":34496.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":384737,"source":{"system":"sec-edgar","filing":"0001415889-22-005629","document":"form4-05242022_040517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922005629/form4-05242022_040517.xml","form_type":"4"}},{"id":2377313,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2022-02-23T23:25:31.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":20377,"price":9.61,"value":195822.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":388684,"source":{"system":"sec-edgar","filing":"0001415889-22-001697","document":"form4-02232022_030221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922001697/form4-02232022_030221.xml","form_type":"4"}},{"id":2483440,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2021-12-07T00:51:33.000Z","date":"2021-12-02","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":409061,"source":{"system":"sec-edgar","filing":"0001179110-21-010636","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021010636/edgar.xml","form_type":"4"}},{"id":2497115,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, DEVELOPMENT"}}],"security":"Ordinary Shares","published_at":"2021-11-24T01:23:27.000Z","date":"2021-11-19","kind":"tax_withholding","acquired":false,"shares":4263,"price":8.36,"value":35638.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."},{"field":"valueOwnedAfter","element":"valueOwnedFollowingTransaction","label":"F2","text":"Includes 119 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2021."}],"source":{"system":"sec-edgar","filing":"0001415889-21-005468","document":"form4-11232021_051117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588921005468/form4-11232021_051117.xml","form_type":"4"}},{"id":2591890,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2021-08-24T22:52:25.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":6819,"price":14.05,"value":95806.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":173205,"source":{"system":"sec-edgar","filing":"0001179110-21-008392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021008392/edgar.xml","form_type":"4"}},{"id":2698228,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2021-05-24T22:09:07.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":3410,"price":17.8,"value":60698.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,282 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021."}],"balance_after":180024,"source":{"system":"sec-edgar","filing":"0001179110-21-005840","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021005840/edgar.xml","form_type":"4"}},{"id":2838136,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2021-02-23T23:03:18.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":6597,"price":18.79,"value":123957.63,"ownership":{"direct":true},"balance_after":182152,"source":{"system":"sec-edgar","filing":"0001179110-21-002154","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021002154/edgar.xml","form_type":"4"}},{"id":2868536,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2021-02-10T23:30:31.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":188749,"source":{"system":"sec-edgar","filing":"0001179110-21-001543","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021001543/edgar.xml","form_type":"4"}},{"id":2941893,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2020-12-16T23:09:54.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":7500,"price":19.4744,"value":146058.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $19.46 to $19.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":123749,"source":{"system":"sec-edgar","filing":"0001179110-20-012003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020012003/edgar.xml","form_type":"4"}},{"id":2967450,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2020-11-24T23:14:44.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":3876,"price":17.21,"value":66705.96,"ownership":{"direct":true},"balance_after":131249,"source":{"system":"sec-edgar","filing":"0001179110-20-011365","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020011365/edgar.xml","form_type":"4"}},{"id":3038571,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2020-09-03T22:10:26.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":135125,"source":{"system":"sec-edgar","filing":"0001179110-20-009566","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020009566/edgar.xml","form_type":"4"}},{"id":3048388,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":93980,"kind":"person","name":"GRAHAM RICHARD A","position":1,"cik":"0001820036","reported_name":"GRAHAM RICHARD A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Development"}}],"security":"Ordinary Shares","published_at":"2020-08-24T22:20:31.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":6598,"price":18.22,"value":120215.56,"ownership":{"direct":true},"balance_after":107625,"source":{"system":"sec-edgar","filing":"0001179110-20-009261","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020009261/edgar.xml","form_type":"4"}}]}